Stay updated on Risdiplam in SMA Infants Clinical Trial
Sign up to get notified when there's something new on the Risdiplam in SMA Infants Clinical Trial page.

Latest updates to the Risdiplam in SMA Infants Clinical Trial page
- Check2 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedA banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.SummaryDifference1%

- Check16 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.0.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, indicating access is blocked; the rendered page includes the site's header and footer with the 403 message.SummaryDifference19%

- Check44 days agoChange DetectedThe page now shows revision v3.7.0, replacing the previous v3.6.6. This indicates a version update to the page rendering system.SummaryDifference0.1%

- Check65 days agoChange DetectedThe study record now includes two additional NIH grant/contract identifiers (2018 and 2023) in the Other Study ID Numbers. The Revision tag has been updated from v3.6.5 to v3.6.6.SummaryDifference0.2%

Stay in the know with updates to Risdiplam in SMA Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Infants Clinical Trial page.